|
|
???tair.name??? >
???browser.page.title.author???
|
"huang s f"???jsp.browse.items-by-author.description???
Showing items 1-10 of 246 (25 Page(s) Totally)
1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page
| 國立成功大學 |
2023 |
COVID-19 associated mold infections: Review of COVID-19 associated pulmonary aspergillosis and mucormycosis
|
Huang, S.-F.;Ying-Jung, Wu A.;Shin-Jung, Lee S.;Huang, Y.-S.;Lee, C.-Y.;Yang, T.-L.;Wang, H.-W.;Chen, H.J.;Chen, Y.C.;Ho, T.-S.;Kuo, C.-F.;Lin, Y.-T. |
| 國立成功大學 |
2023 |
Recommendations and guidelines for the diagnosis and management of Coronavirus Disease-19 (COVID-19) associated bacterial and fungal infections in Taiwan
|
Wu, H.-Y.;Chang, P.-H.;Huang, Y.-S.;Tsai, C.-S.;Chen, K.-Y.;Lin, I.-F.;Hsih, W.-H.;Tsai, W.-L.;Chen, J.-A.;Yang, T.-L.;Lee, C.-Y.;Ho, T.-S.;Wang, H.-W.;Huang, S.-F.;Wu, A.Y.-J.;Chen, H.-J.;Chen, Y.-C.;Chen, W.-C.;Tseng, C.-H.;Lin, P.-C.;Yang, C.-H.;Hong, P.-L.;Lee, S.S.-J.;Chen, Y.-S.;Liu, Y.-C.;Wang, F.-D.;Chan, Y.-J.;Chang, F.-Y.;Chang, H.-T.;Chen, Y.-C.;Chen, Y.-H.;Cheng, M.-F.;Chi, H.;Chiu, Chiu C.-H.;Ho, M.-W.;Hsieh, S.-M.;Hsueh, P.-R.;Huang, C.-H.;Hung, C.-C.;Hwang, K.-P.;Kao, Kao K.-C.;Ko, W.-C.;Kuo, C.-F.;Lai, C.-H.;Lee, N.-Y.;Lee, S.-J.;Lin, H.-H.;Lin, Y.-T.;Liu, C.-C.;Liu, P.-Y.;Lu, P.-L.;Lu, C.-Y.;Sheng, W.-H.;Tang, H.-J.;Tsai, H.-C.;Wu, T.-S.;Yang, C.-J. |
| 臺大學術典藏 |
2022-09-15T09:48:02Z |
Clinical Outcomes of Taiwanese Patients with Resected Oral Cavity Squamous Cell Carcinoma Who Underwent Reconstruction with Free Versus Local Flaps
|
Liao C.-T.; Wen Y.-W.; Lee S.-R.; Ng S.-H.; Liu T.-W.; Tsai S.-T.; Tsai M.-H.; Lin J.-C.; Chien C.-Y.; PEI-JEN LOU; Wang C.-P.; Chu P.-Y.; Leu Y.-S.; Tsai K.-Y.; Terng S.-D.; Chen T.-M.; Wang C.-H.; Chen W.-C.; Lee L.-Y.; Lin C.-Y.; Wang H.-M.; Fang T.-J.; Huang S.-F.; Kang C.-J.; Chang K.-P.; Yen T.-C.; Yang L.-Y.; Lin C.-H.; for the Taiwan Oral Cavity Cancer Advisory Group |
| 臺大學術典藏 |
2022-08-19T00:20:43Z |
Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer
|
Chiang N.-J.; CHIUN HSU; Chen J.-S.; Tsou H.-H.; Shen Y.-Y.; Chao Y.; Chen M.-H.; Yeh T.-S.; Shan Y.-S.; Huang S.-F.; Chen L.-T. |
| 臺大學術典藏 |
2022-08-19T00:20:39Z |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group; Ni Y.-H.; Lin C.-L.; Hsu Y.-C.; Hsu C.-W.; Wu C.-Y.; Wu J.-C.; Cheng J.C.-H.; Leung S.W.; Chen S.-W.; Hsu H.-C.; Hong J.-H.; Wang P.-M.; Wang P.-M.; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Ho M.-C.; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; Cheng A.-L.; CHIUN HSU; Chao Y.; Chen L.-T.; Lee P.-H.; Liao L.-Y.; Huo T.-I.; Wu C.-C.; Hung C.-F.; Huang S.-F.; Yang S.-S.; Chen R.-C.; Chen C.-H.; Dai C.-Y.; Wang T.-E.; Su C.-W.; Wang J.-H.; Lu S.-N. |
| 臺大學術典藏 |
2022-08-12T06:27:43Z |
Major functional transcriptome of an inferred center regulator of an ER(-) breast cancer model system
|
Liu L.-Y.D.; Chang L.-Y.; Kuo W.-H.; Hwa H.-L.; Lin Y.-S.; Huang S.-F.; Chen C.-N.; KING-JEN CHANG; Hsieh F.-J. |
| 臺大學術典藏 |
2022-07-15T08:18:10Z |
Clinicopathologic study of satellite lesions in nontuberculous mycobacterial keratitis
|
FUNG-RONG HU; Huang W.-J.; Huang S.-F. |
| 臺大學術典藏 |
2022-06-27T07:07:39Z |
Different efficacies of erlotinib and gefitinib in Taiwanese patients with advanced non-small cell lung cancer: A retrospective multicenter study
|
Fan W.-C.; CHONG-JEN YU; Tsai C.-M.; Huang M.-S.; Lai C.-L.; Hsia T.-C.; Tien Y.-J.; Huang S.-F.; Wu C.-H.; Chou K.-T.; Lee Y.-C.; Perng R.-P.; Chen Y.-M. |
| 臺大學術典藏 |
2022-06-27T07:06:29Z |
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
|
Bean J.; Brennan C.; Shih J.-Y.; Riely G.; Viale A.; Wang L.; Chitale D.; Motoi N.; Szoke J.; Broderick S.; Balak M.; Chang W.-C.; CHONG-JEN YU; Gazdar A.; Pass H.; Rusch V.; Gerald W.; Huang S.-F.; Yang P.-C.; Miller V.; Ladanyi M.; Yang C.-H.; Pao W. |
| 臺大學術典藏 |
2022-06-27T07:06:27Z |
Incidence and significance of clinically abnormal events in a Tertiary Referral Medical Center: Implementation of the Clinical Alert System (CAS)
|
Jerng J.-S.; Ko W.-J.; Lu F.L.; Chen Y.-S.; Huang S.-F.; CHONG-JEN YU; Wang M.-J.; Lin F.-Y. |
Showing items 1-10 of 246 (25 Page(s) Totally)
1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page
|
